144 related articles for article (PubMed ID: 25715695)
21. Investigation of endogenous compounds for assessing the drug interactions in the urinary excretion involving multidrug and toxin extrusion proteins.
Kato K; Mori H; Kito T; Yokochi M; Ito S; Inoue K; Yonezawa A; Katsura T; Kumagai Y; Yuasa H; Moriyama Y; Inui K; Kusuhara H; Sugiyama Y
Pharm Res; 2014 Jan; 31(1):136-47. PubMed ID: 23907530
[TBL] [Abstract][Full Text] [Related]
22. The involvement of multidrug and toxin extrusion protein 1 in the distribution and excretion of berberine.
Xiao L; Xue Y; Zhang C; Wang L; Lin Y; Pan G
Xenobiotica; 2018 Mar; 48(3):314-323. PubMed ID: 28298174
[TBL] [Abstract][Full Text] [Related]
23. Effect of cephalexin on the pharmacokinetics of metformin in healthy human volunteers.
Jayasagar G; Krishna Kumar M; Chandrasekhar K; Madhusudan Rao C; Madhusudan Rao Y
Drug Metabol Drug Interact; 2002; 19(1):41-8. PubMed ID: 12222753
[TBL] [Abstract][Full Text] [Related]
24. Targeted disruption of organic cation transporter 3 attenuates the pharmacologic response to metformin.
Chen EC; Liang X; Yee SW; Geier EG; Stocker SL; Chen L; Giacomini KM
Mol Pharmacol; 2015 Jul; 88(1):75-83. PubMed ID: 25920679
[TBL] [Abstract][Full Text] [Related]
25. Transporters as a determinant of drug clearance and tissue distribution.
Shitara Y; Horie T; Sugiyama Y
Eur J Pharm Sci; 2006 Apr; 27(5):425-46. PubMed ID: 16488580
[TBL] [Abstract][Full Text] [Related]
26. In Vivo Imaging of Human 11C-Metformin in Peripheral Organs: Dosimetry, Biodistribution, and Kinetic Analyses.
Gormsen LC; Sundelin EI; Jensen JB; Vendelbo MH; Jakobsen S; Munk OL; Hougaard Christensen MM; Brøsen K; Frøkiær J; Jessen N
J Nucl Med; 2016 Dec; 57(12):1920-1926. PubMed ID: 27469359
[TBL] [Abstract][Full Text] [Related]
27. PET imaging-based evaluation of hepatobiliary transport in humans with (15R)-11C-TIC-Me.
Takashima T; Kitamura S; Wada Y; Tanaka M; Shigihara Y; Ishii H; Ijuin R; Shiomi S; Nakae T; Watanabe Y; Cui Y; Doi H; Suzuki M; Maeda K; Kusuhara H; Sugiyama Y; Watanabe Y
J Nucl Med; 2012 May; 53(5):741-8. PubMed ID: 22499612
[TBL] [Abstract][Full Text] [Related]
28. Metoprolol decreases the plasma exposure of metformin via the induction of liver, kidney and muscle uptake in rats.
Ma YR; Shi AX; Qin HY; Zhang T; Wu YF; Zhang GQ; Wu XA
Biopharm Drug Dispos; 2016 Dec; 37(9):511-521. PubMed ID: 27662517
[TBL] [Abstract][Full Text] [Related]
29. Metformin sinusoidal efflux from the liver is consistent with negligible biliary excretion and absence of enterohepatic cycling.
Zamek-Gliszczynski MJ; Bao JQ; Day JS; Higgins JW
Drug Metab Dispos; 2013 Nov; 41(11):1967-71. PubMed ID: 24009308
[TBL] [Abstract][Full Text] [Related]
30. Genetic variants of the organic cation transporter 2 influence the disposition of metformin.
Song IS; Shin HJ; Shim EJ; Jung IS; Kim WY; Shon JH; Shin JG
Clin Pharmacol Ther; 2008 Nov; 84(5):559-62. PubMed ID: 18401339
[TBL] [Abstract][Full Text] [Related]
31. Liver uptake of biguanides in rats.
Sogame Y; Kitamura A; Yabuki M; Komuro S
Biomed Pharmacother; 2011 Sep; 65(6):451-5. PubMed ID: 21880461
[TBL] [Abstract][Full Text] [Related]
32. Lonicera japonica extract increases metformin distribution in the liver without change of systemic exposed metformin in rats.
Han SY; Chae HS; You BH; Chin YW; Kim H; Choi HS; Choi YH
J Ethnopharmacol; 2019 Jun; 238():111892. PubMed ID: 31004727
[TBL] [Abstract][Full Text] [Related]
33. Multidrug and toxin extrusion protein 1-mediated interaction of metformin and Scutellariae radix in rats.
Yim S; You BH; Chae HS; Chin YW; Kim H; Choi HS; Choi YH
Xenobiotica; 2017 Nov; 47(11):998-1007. PubMed ID: 27817253
[TBL] [Abstract][Full Text] [Related]
34. Gender-Related Differences in the Expression of Organic Cation Transporter 2 and its Role in Urinary Excretion of Metformin in Rats.
Ma YR; Qin HY; Jin YW; Huang J; Han M; Wang XD; Zhang GQ; Zhou Y; Rao Z; Wu XA
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):559-65. PubMed ID: 25876759
[TBL] [Abstract][Full Text] [Related]
35. Metformin targets brown adipose tissue in vivo and reduces oxygen consumption in vitro.
Breining P; Jensen JB; Sundelin EI; Gormsen LC; Jakobsen S; Busk M; Rolighed L; Bross P; Fernandez-Guerra P; Markussen LK; Rasmussen NE; Hansen JB; Pedersen SB; Richelsen B; Jessen N
Diabetes Obes Metab; 2018 Sep; 20(9):2264-2273. PubMed ID: 29752759
[TBL] [Abstract][Full Text] [Related]
36. Involvement of carnitine/organic cation transporter OCTN1/SLC22A4 in gastrointestinal absorption of metformin.
Nakamichi N; Shima H; Asano S; Ishimoto T; Sugiura T; Matsubara K; Kusuhara H; Sugiyama Y; Sai Y; Miyamoto K; Tsuji A; Kato Y
J Pharm Sci; 2013 Sep; 102(9):3407-17. PubMed ID: 23666872
[TBL] [Abstract][Full Text] [Related]
37. Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics.
Shu Y; Brown C; Castro RA; Shi RJ; Lin ET; Owen RP; Sheardown SA; Yue L; Burchard EG; Brett CM; Giacomini KM
Clin Pharmacol Ther; 2008 Feb; 83(2):273-80. PubMed ID: 17609683
[TBL] [Abstract][Full Text] [Related]
38. Cynomolgus Monkey as a Clinically Relevant Model to Study Transport Involving Renal Organic Cation Transporters: In Vitro and In Vivo Evaluation.
Shen H; Liu T; Jiang H; Titsch C; Taylor K; Kandoussi H; Qiu X; Chen C; Sukrutharaj S; Kuit K; Mintier G; Krishnamurthy P; Fancher RM; Zeng J; Rodrigues AD; Marathe P; Lai Y
Drug Metab Dispos; 2016 Feb; 44(2):238-49. PubMed ID: 26608080
[TBL] [Abstract][Full Text] [Related]
39. Disposition of metformin: variability due to polymorphisms of organic cation transporters.
Zolk O
Ann Med; 2012 Mar; 44(2):119-29. PubMed ID: 21366511
[TBL] [Abstract][Full Text] [Related]
40. Ablation of both organic cation transporter (OCT)1 and OCT2 alters metformin pharmacokinetics but has no effect on tissue drug exposure and pharmacodynamics.
Higgins JW; Bedwell DW; Zamek-Gliszczynski MJ
Drug Metab Dispos; 2012 Jun; 40(6):1170-7. PubMed ID: 22407892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
